Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to slash deadly ICU pneumonia with nurse training and simple tools

NCT ID NCT06624540

Knowledge-focused Sponsor: Hiroshima University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether training intensive care nurses in evidence-based practices and providing new equipment (like closed suction catheters and mouth care brushes) can lower the rate of ventilator-associated pneumonia (VAP) in a Bangladesh hospital. Researchers will compare infection rates and patient outcomes before and after the training and equipment rollout. About 272 patients and their nurses will take part, with the goal of improving care quality and reducing preventable infections.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse training and new equipment (closed suction catheter, endotracheal tube, suction device, mouth care brush)
What this could lead to
If successful, this could show a practical way to reduce serious lung infections in ICU patients, improving survival and shortening hospital stays.
What could go wrong
This is a small, early-stage study at one hospital, so results may not apply elsewhere. It compares current data to past records, which can be less reliable than a randomized trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 272 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Study 2: Inclusion criteria: * Who will be a registered nurse in Bangladesh. * Who will agree to participate in this study and the EBP training. Exclusion criteria: * Who will not directly involve patient care in ICU. Study 3: Inclusion Criteria: * Irrespective of age and sex, participant must be 18 years old. * Legal guardian of a patient consents to participation in the study * Intubated patients after admission. Exclusion Criteria: * Who stays less than 2 days at the GICU. * Who dies or is extubated within 2 days after admitted in the GICU. * ICU readmission.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Evidence-based practice are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Evidence-based practice Ventilator-associated pneumonia (VAP)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dhaka Medical College Hospital

    RECRUITING

    Dhaka, Bangladesh

  • Hiroshima University

    NOT_YET_RECRUITING

    Hiroshima, Kasumi 1-2-3 Minami-ku, 734-8553, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.